Skip to main content

Featured

Testing compliance checks done

The Government today completed enforcement operations at Block 6 of Hanford Garden in Tuen Mun and Goldwin Heights at 2 Seymour Road in Mid-Levels, which were earlier included in compulsory testing notices.   The Civil Service Bureau conducted the Tuen Mun enforcement action from around 8.30am to 11.30am, while the Central & Western District Office carried out the Mid-Levels operation from around 8am to 11am.   Both actions were conducted together with Police and the Department of Health.   The Government arranged for staff to verify the testing certifications of people subject to compulsory testing at the buildings’ entrances and exits.   During the operations, the test records of about 200 people in Block 6 of Hanford Garden and about 430 people in Goldwin Heights were checked.   As a result, seven people in total were found to have violated the compulsory testing notice and were issued with a compulsory testing order.    A fixed penalty notice of $10,000 was also iss

Vaccine packaging issue probed

(To watch the full media session with sign language interpretation, click here.)   An investigation by BioNTech has revealed that packaging defects in its COVID-19 vaccine vials were caused by the crimping process and ultra-low storage temperature but did not affect the jabs' safety.   Director of Health Dr Constance Chan told a media session this afternoon that the Department of Health received a written notification from BioNTech today on its investigation into the packaging issue.   Dr Chan said: “Upon further investigation, samples (of the BioNTech vaccine vials with packaging defects) detected in Hong Kong were sent back to Germany for an investigation. They have done numerous tests and experiments on the vials concerned. They have also done tests in another fill and finish plant operated by Baxter.   “In the process, they found out that in the vials packed at the site which provided batches (numbered) 210102 and 210104, there were issues related to the so-called crimping process. Crimping is the process by which pressure is applied to the aluminium ring which affixes to the rubber stopper at the top of the vial.   “We received a report that the (defect in question) is related to the process of crimping and at the same time the condition of the ultra-low temperature of minus 70 degrees Celsius. So that is why BioNTech has now decided to send the new vials from Baxter which have undergone repeated experiments and investigations, and that would exclude further occurrence of such an event.”
http://dlvr.it/RwqJtL

Popular Posts